AR072212A1 - Una composicion farmaceutica que comprende rebamipida - Google Patents

Una composicion farmaceutica que comprende rebamipida

Info

Publication number
AR072212A1
AR072212A1 ARP090102253A ARP090102253A AR072212A1 AR 072212 A1 AR072212 A1 AR 072212A1 AR P090102253 A ARP090102253 A AR P090102253A AR P090102253 A ARP090102253 A AR P090102253A AR 072212 A1 AR072212 A1 AR 072212A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
group
aminoazucar
agent
rebamipida
Prior art date
Application number
ARP090102253A
Other languages
English (en)
Inventor
Sun-Ichiro Sumida
Shinichi Ishikawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR072212A1 publication Critical patent/AR072212A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composicion farmaceutica que contiene rebamipida, la cual no necesita redispersarse, tiene una suficiente transparencia y exhibe pH neutro a ligeramente  cido para no danar la queratoconjuntiva de un paciente que sufre de ojo seco. La presente composicion farmaceutica comprende (1) rebamipida, (2) un aminoazucar, y (3) un agente buffer, que no tiene cation inorg nico. Reivindicacion 2: La composicion farmaceutica de la reivindicacion 1 en donde el aminoazucar es al menos uno seleccionado del grupo que consiste en D-glucosamina y meglumina. Reivindicacion 3: La composicion farmaceutica de la reivindicacion 1 o 2 en donde el agente buffer es al menos uno seleccionado del grupo que consiste en  cido borico,  cido fosforico y un amino cido. Reivindicacion 5: La composicion farmaceutica de cualquiera de las reivindicaciones 1 a 4, que adem s comprende un agente solubilizante. Reivindicacion 6: La composicion farmaceutica de la reivindicacion 5 en donde el agente solubilizante es al menos uno seleccionado del grupo que consiste en polivinilpirrolidona y macrogol. Reivindicacion 8: Uso de la composicion farmaceutica de cualquiera de las reivindicaciones 1 a 7 para tratar el ojo seco por administracion topica en los ojos.
ARP090102253A 2008-06-19 2009-06-19 Una composicion farmaceutica que comprende rebamipida AR072212A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008160084 2008-06-19

Publications (1)

Publication Number Publication Date
AR072212A1 true AR072212A1 (es) 2010-08-11

Family

ID=41334556

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102253A AR072212A1 (es) 2008-06-19 2009-06-19 Una composicion farmaceutica que comprende rebamipida

Country Status (27)

Country Link
US (1) US20110124682A1 (es)
EP (1) EP2285413B1 (es)
JP (1) JP5441934B2 (es)
KR (1) KR20110027786A (es)
CN (1) CN102099056B (es)
AR (1) AR072212A1 (es)
AU (1) AU2009261101B2 (es)
BR (1) BRPI0915427A2 (es)
CA (1) CA2725487A1 (es)
CO (1) CO6280502A2 (es)
CY (1) CY1113214T1 (es)
DK (1) DK2285413T3 (es)
ES (1) ES2389583T3 (es)
HK (1) HK1149496A1 (es)
HR (1) HRP20120644T1 (es)
IL (1) IL209329A (es)
MX (1) MX2010013733A (es)
MY (1) MY150558A (es)
NZ (1) NZ589517A (es)
PL (1) PL2285413T3 (es)
PT (1) PT2285413E (es)
RU (1) RU2538694C2 (es)
SI (1) SI2285413T1 (es)
TW (1) TWI495634B (es)
UA (1) UA100164C2 (es)
WO (1) WO2009154304A2 (es)
ZA (1) ZA201008584B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201322982A (zh) 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
TW201417814A (zh) * 2012-09-28 2014-05-16 Otsuka Pharma Co Ltd 包括瑞巴派特之醫藥組成物
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015034008A1 (ja) * 2013-09-05 2015-03-12 大塚製薬株式会社 レバミピドの局所止血用途
JP6854587B2 (ja) * 2015-04-17 2021-04-07 ロート製薬株式会社 医薬製剤
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
US11324829B2 (en) 2016-03-14 2022-05-10 Santen Pharmaceutical Co., Ltd. Antiseptic agent comprising meglumine or salt thereof
CN106491530B (zh) * 2016-12-13 2019-11-29 湖北远大天天明制药有限公司 一种眼用药物组合物
KR101840256B1 (ko) * 2017-09-21 2018-03-21 대우제약 주식회사 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20200019451A (ko) 2018-08-14 2020-02-24 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
JP6744952B2 (ja) * 2019-05-28 2020-08-19 ロート製薬株式会社 眼科用組成物
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법
KR102659338B1 (ko) 2023-05-18 2024-04-19 국제약품 주식회사 안구건조증 치료용 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法

Also Published As

Publication number Publication date
IL209329A (en) 2014-09-30
PT2285413E (pt) 2012-09-07
BRPI0915427A2 (pt) 2015-11-03
JP2011524854A (ja) 2011-09-08
PL2285413T3 (pl) 2013-01-31
MX2010013733A (es) 2011-01-21
RU2011101713A (ru) 2012-07-27
TWI495634B (zh) 2015-08-11
DK2285413T3 (da) 2012-08-27
KR20110027786A (ko) 2011-03-16
AU2009261101A1 (en) 2009-12-23
CN102099056A (zh) 2011-06-15
EP2285413B1 (en) 2012-08-08
ES2389583T3 (es) 2012-10-29
ZA201008584B (en) 2012-01-25
TW201006800A (en) 2010-02-16
WO2009154304A2 (en) 2009-12-23
MY150558A (en) 2014-01-30
CA2725487A1 (en) 2009-12-23
UA100164C2 (ru) 2012-11-26
CY1113214T1 (el) 2016-04-13
RU2538694C2 (ru) 2015-01-10
HK1149496A1 (en) 2011-10-07
SI2285413T1 (sl) 2012-09-28
NZ589517A (en) 2012-09-28
HRP20120644T1 (hr) 2012-08-31
EP2285413A2 (en) 2011-02-23
US20110124682A1 (en) 2011-05-26
WO2009154304A3 (en) 2010-12-02
JP5441934B2 (ja) 2014-03-12
AU2009261101B2 (en) 2013-11-07
IL209329A0 (en) 2011-01-31
CN102099056B (zh) 2014-10-01
CO6280502A2 (es) 2011-05-20

Similar Documents

Publication Publication Date Title
AR072212A1 (es) Una composicion farmaceutica que comprende rebamipida
CR20150199A (es) Análogos de 2´-cloro nucleósido para infección por vhc
BR112015026006A2 (pt) métodos para o tratamento de câncer com o uso de terapia de combinação com inibidor de cinase tor
PH12014502603A1 (en) D-amino acid compounds for liver disease
BR112015021549A2 (pt) inibidores de piridina cinase cdk9
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112012012529A2 (pt) composto indol e seu uso farmacêutico
BR112015032340A2 (pt) composições e artigos para cuidados pessoais
BR112014017716A8 (pt) composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
BR112015007778A2 (pt) profármacos neutralizantes de vegf para o tratamento de condições oculares
BR112014010590A2 (pt) 18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
BR112015017405A2 (pt) composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112012026338A2 (pt) novos derivados de 3,3-dimetil tetrahidroquinolina
BR112015020772A2 (pt) compostos de pirimidina e piridina e seu uso
BR112014029708A8 (pt) Composto de pirrolo[2,1-f][1,2,4]triazina, método de preparação de compostos de pirrolo[2,1-f][1,2,4]triazina e uso do composto de pirrolo[2,1-f][1,2,4]triazina
AR070025A1 (es) Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
BR112015023161A2 (pt) derivados de piridin-4-ila
BR112015029853A2 (pt) uso de uma composição farmacêutica
BR112015022982A2 (pt) inibidores macrocíclicos de rip2 quinase
BR112015023356A2 (pt) inibidores de quinase pirrol[2,3-b]piridina cdk9
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
BR112015005347A2 (pt) composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids
MX368635B (es) Compuestos tricíclicos de piperidina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure